Zio ECG Utilization Software (ZEUS) System vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Ligence

AI Verdict

These tools are adjacent in the broader cardiology AI space, but not direct competitors. The Zio ECG Utilization Software (ZEUS) System specializes in AI-powered analysis of continuous ECG data from wearable monitors for arrhythmia detection. In contrast, Ligence Heart focuses on automating the analysis and reporting of 2D transthoracic echocardiography for structural and functional heart assessment.

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if your primary need is continuous, long-term ECG monitoring for the detection and management of cardiac arrhythmias. This cloud-based platform excels at analyzing extended periods of wearable ECG data, making it ideal for identifying intermittent or elusive heart rhythm disorders over several days. It's particularly well-suited for practices looking to leverage AI-powered insights from wearable biosensors to streamline arrhythmia diagnosis and ongoing patient management.

View Zio ECG Utilization Software (ZEUS) System →

Choose Ligence Heart if…

Choose Ligence Heart if your focus is on automating and enhancing the analysis and reporting of 2D transthoracic echocardiography studies. This AI-powered platform is designed to significantly improve the efficiency and accuracy of cardiologists and sonographers by automating measurements, view classification, and report generation from echo images. It is best suited for clinics and hospitals seeking to optimize their echocardiography workflow, reduce manual interpretation time, and improve consistency in diagnosing various cardiac conditions based on echo data.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio ECG Utilization Software (ZEUS) System Ligence Heart
Pricing Unknown Contact-for-pricing
Deployment Cloud-based. Cloud-based; on-premise; hybrid
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart emphasizes an intuitive interface and the elimination of manual tracing in echocardiography analysis, which directly addresses a significant pain point for cardiologists and sonographers, leading to reported time savings. While ZEUS offers a web portal and mobile app for healthcare professionals and aims for patient simplicity, Ligence Heart's specific focus on automating complex manual tasks provides a more distinct usability advantage in its domain.

Clinical Value

Ligence Heart

Both tools demonstrate strong clinical value with robust validation. ZEUS has a large body of evidence and shows superior performance in arrhythmia detection compared to other monitoring types. However, Ligence Heart has a landmark study demonstrating that its AI outperformed human experts in specific echocardiography measurements (left ventricular mass) when compared to a gold standard (CT scans), which is a particularly compelling claim of enhanced diagnostic accuracy.

Pricing & Value

Tie

Both Zio ECG Utilization Software (ZEUS) System and Ligence Heart employ opaque pricing models, requiring direct contact with the vendor for details. Neither product provides publicly available pricing information or specific value-based pricing structures. Therefore, it is not possible to differentiate between the two on this dimension.

Enterprise Readiness

Ligence Heart

Ligence Heart offers greater deployment flexibility with cloud, on-premise, and hybrid options, which is a significant advantage for large enterprises with diverse IT infrastructure and data governance requirements. Both tools provide EHR integration and possess necessary regulatory clearances and compliance, but Ligence Heart's adaptable deployment model gives it an edge in enterprise readiness.

Innovation

Ligence Heart

Both tools are highly innovative in their respective fields. ZEUS leverages AI for long-term wearable ECG monitoring and arrhythmia detection, including the Zio Watch for AFib burden. However, Ligence Heart's innovation is particularly notable for automating complex echocardiography analysis, with a landmark study demonstrating its AI's ability to outperform human experts in specific measurements, and it has received industry recognition like the EIT Health InnoStars Awards.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

iRhythm Technologies (Tool A) offers comprehensive support, including 24/7 phone and email support for both patients and healthcare providers, along with specialized teams for billing and inventory management. Ligence (Tool B) mentions email support and user manuals, but lacks the detailed, round-the-clock, and multi-faceted support structure described for Tool A.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio ECG Utilization Software (ZEUS) System Ligence Heart
Tool Name Zio ECG Utilization Software (ZEUS) System Ligence Heart
Company iRhythm Technologies Ligence
Description The Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers.
Primary Data Analyzed Continuous ECG data from wearable Zio monitors 2D transthoracic echocardiography
Key Features (Examples) AI algorithm for arrhythmia detection and classification, Continuous ECG data analysis (up to 14 days), Cloud-based data analytics (AWS EC2 platform) Automated recognition of echocardiography imaging data, Automated view classification and heart phase prediction, Automated calculation of measurements and report generation
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology
EHR/PACS Integration HL7-based EHR integration Integration with existing systems (PACS, EHR, RIS)

Videos

Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and Ligence Heart.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data from wearable Zio monitors to aid in the diagnosis and management of cardiac arrhythmias. Ligence Heart, on the other hand, automates the analysis and reporting of 2D transthoracic echocardiography imaging data.
ZEUS is designed to assist physicians with arrhythmia detection and classification through continuous ECG data analysis for up to 14 days. Ligence Heart enhances diagnostic efficiency and accuracy for cardiologists and sonographers by automating echocardiography analysis, including automated measurements, report generation, and disease recognition for conditions like heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases.
ZEUS offers HL7-based EHR integration and provides access via its ZioSuite web portal and mobile application for healthcare professionals. Ligence Heart integrates with existing systems such as PACS, EHR, and RIS, and facilitates the transfer of echocardiography images (with PHI removed) from hospital PACS.
ZEUS is designed to support Cardiology, Family Medicine, and Internal Medicine. Ligence Heart is specifically tailored for use within Cardiology.
ZEUS utilizes proprietary deep-learned algorithms for arrhythmia detection and classification from continuous ECG data. Ligence Heart provides automated recognition of echocardiography imaging data, view classification, heart phase prediction, automated calculation of measurements (Area, Distance, Doppler, Volume, Strain), and disease recognition.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.